DURHAM, N.C., January 29, 2025--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS ® platform to develop in ...
Additionally, Cassie Gorsuch, PhD has been promoted to Chief Scientific Officer overseeing non-clinical development and gene therapy discovery. Dr. Gorsuch will be responsible for preclinical ...
Additionally, Cassie Gorsuch, PhD has been promoted to Chief Scientific Officer overseeing non-clinical development and gene therapy discovery. Dr. Gorsuch will be responsible for preclinical proof of ...